News
2hOpinion
New Scientist on MSNWe should consider testing Ozempic on healthy peopleAs the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...
Cheryl Burke is setting the record straight about her weight loss after months of facing Ozempic and cosmetic surgery rumors.
Ozempic isn’t just for weight loss—studies show it could help prevent strokes. Discover what this means for you, and what ...
Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, agrees. “Lowering a person’s ...
Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...
21h
Interesting Engineering on MSNOzempic-style obesity drug bypasses neurons, avoids nausea and vomiting side effectsA new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...
Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...
Ripped Jeans and Bifocals on MSN3h
Flying with Ozempic: What You Need to Know Before You TravelIf you’re one of the many people using Ozempic (semaglutide) to manage type 2 diabetes or for weight loss under medical ...
CINCINNATI — U.S. Customs and Border Protection (CBP) and the U.S. Food and Drug Administration (FDA) at the port of ...
European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.
Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...
On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results